Aardvark Therapeutics, Inc. (AARD) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts AARD Hot Sheet
Join SI Premium – FREE
Aardvark Therapeutics, Inc. (NASDAQ: AARD) reported Q3 EPS of ($0.75), $0.02 better than the analyst estimate of ($0.77).
For earnings history and earnings-related data on Aardvark Therapeutics, Inc. (AARD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Myriad Uranium completes acquisition of Rush Rare Metals
- CoVolt Power files for proposed IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
